Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
757.70 | -47,9% | -26,52% | 682.237,16 | 0,68% | 2,63% |
|
NYSE:JNJ
Johnson & Johnson
|
151.22 | 0% | 0% | 363.938,03 | 3,31% | 2,71% |
|
NYSE:PFE
Pfizer
|
28.44 | 9,18% | 39,63% | 161.157,9 | 6% | -9,31% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
429.93 | 1,37% | 9,4% | 110.944,89 | 0% | 30,14% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
976.96 | -29,21% | -23,18% | 105.399,82 | 0% | 13,9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
45.06 | 58,04% | 68,14% | 91.341,13 | 5,34% | 13,54% |
|
NYSE:ZTS
Zoetis
|
167.91 | 31,76% | 48,08% | 76.616,52 | 1,02% | 11,19% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
149.89 | 0% | 0% | 18.959,85 | 0% | 0% |
|
NYSE:BAX
Baxter International Inc
|
35.43 | 81,85% | 109,28% | 18.054,43 | 3,25% | -3,14% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.36 | 5,13% | 15,66% | 13.324,53 | 4,3% | -8,55% |
|
NasdaqGS:UTHR
United Therapeutics
|
264.34 | -10,71% | -1,33% | 11.803,71 | 0% | 5,22% |
|
NYSE:CTLT
Catalent
|
55.80 | -57,27% | -6,76% | 10.100,49 | 0% | -10,41% |
|
NasdaqGS:CYTK
Cytokinetics
|
57.89 | 0% | 0% | 6.707,63 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
38.80 | -.156,68% | -.149,23% | 5.756,54 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
154.46 | -9,31% | -0,59% | 5.026,29 | 0,51% | 5,85% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
211.32 | 0% | 0% | 4.409,78 | 0% | 0% |
|
NasdaqGS:NEOG
Neogen
|
12.84 | 133,55% | 233,03% | 2.692,43 | 0% | -1,7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
27.53 | -34,78% | -10,92% | 2.552,83 | 0% | 2,03% |
|
LSE:INDV
Indivior PLC
|
14.38 | -23,61% | -1,68% | 1.952,43 | 0% | -2,7% |
|
NasdaqCM:TGTX
TG Therapeutics
|
17.32 | 0% | 0% | 2.379,32 | 0% | 0% |
